Barinat 4 Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Baricitinib (4mg)
Overview Barinat 4 Tablet
For hospitalized adults with COVID-19, Remdesivir therapy often includes the adjunct medication Barinat 4 Tablet. This medication may be taken with or without food, but consistent daily timing is recommended. Dosage is individualized based on your health status and other medications. Always follow your physician's instructions; discontinuation should only occur under their guidance, as premature cessation could worsen your condition. Commonly reported side effects include upper respiratory tract infections, nausea, and viral infections; other symptoms may mimic a common cold (runny nose, sneezing, sore throat), or manifest as cold sores or general malaise. Less frequent, but potentially serious, adverse events such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Discuss any concerns regarding side effects with your doctor. Pre-treatment blood work may be required, and initiation of Barinat 4 Tablet is contraindicated in the presence of any infection. Prior to commencing treatment, inform your physician of any history of tuberculosis, shingles, hepatic or renal impairment, hepatitis B or C, or thromboembolic events. Barinat 4 Tablet may increase susceptibility to infection or exacerbate existing ones; therefore, minimize contact with individuals exhibiting contagious illnesses (e.g., influenza, measles, varicella). This medication is not appropriate for individuals under 18 years of age or during pregnancy or breastfeeding, unless the physician deems the benefits outweigh the risks. Regular check-ups with your doctor may be necessary.
Primary Ingredients of Barinat 4 Tablet
No information provided. Unable to rephrase.
Uses of Barinat 4 Tablet
Managing Coronavirus infection (COVID-19)
Major Benefits of Barinat 4 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Barinat 4 Tablets can be administered with or without food, but consistent timing is recommended.
Common Side effects of Barinat 4 Tablet:
- Upper respiratory tract infection
- Nausea
- Herpes virus infection
- Cold sores
- Viral infection
- Sore throat
How to use Barinat 4 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Barinat 4 Tablets can be administered with or without food, though consistent timing is recommended.
How Barinat 4 Tablet works:
Barinat 4 tablets function by selectively blocking Janus kinase 1 and 2 (JAK1/JAK2). This JAK inhibitor disrupts the JAK-STAT signaling cascade, a crucial cellular communication pathway governing immune responses, cell proliferation, apoptosis, and oncogenesis.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Barinat 4 Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Using Barinat 4 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Barinat 4 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Barinat 4 Tablet.
KidneyUNSAFE
The use of Barinat 4 Tablet is likely inadvisable for individuals with kidney impairment and should be avoided. Seek medical advice.
LiverSAFE IF PRESCRIBED
Patients with liver disease can generally use Barinat 4 Tablet without needing a dose change. However, its use in patients with severe liver disease is unadvised due to insufficient data. Physician consultation is essential.
What if you forget to take Barinat 4 Tablet :
NA
Facts to Know About Barinat 4 Tablet
Label | Value |
---|---|
Chemical Type | Pyrrolopyrimidine Compound |
Developing Habits | No. |
Treatment Category | Pain Relievers |
Actions | JAK inhibitors |